Home › NDC Lookup › Ingredients › Mineral Oil › 00132-0301-40
FLEET Mineral Oil 100 g/100mL Enema, 133 mL — NDC 00132-0301-40 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

FLEET Mineral Oil 100 g/100mL Enema, 133 mL — NDC 0132-0301-40 (Billing 00132-0301-40)

by C.B. Fleet Company, Inc. · 133 mL in 1 BOTTLE, WITH APPLICATOR

This is a package of 133 mL of FLEET Mineral Oil 100 g/100mL Enema from C.B. Fleet Company, Inc., marketed since May 2002 and currently FDA-listed; retail pharmacies pay about $0.0171 per mL (NADAC). It is this product's only package size.

NDC 00132-0301-40
🏷️ FDA NDC (as labeled) 0132-0301-40 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0132-0301-40 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0132 labeler · 0301 product · 40 package
Package marketed since
May 1, 2002
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
133 mL per package
Barcode (UPC-A, from the NDC)
3 0132030140 3
Medicaid fills, this package
908 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0132-0301-40
Product NDC 0132-0301
11-digit billing NDC 00132030140
NCPDP billing unit ML — per mL (volume)
RxCUI 205121
UNII T5L8T28FGP
Application # M007
SPL Set ID 2528cb5e-437e-41f0-9c34-e9ce57404d8b
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2002-05-01
Route RECTAL
Dosage form ENEMA
Substance MINERAL OIL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46400010005110
GPI class Fleet Oil
GCN Seq No 002996
GCN 09049
HICL code 001319
Ingredient (HICL) Mineral Oil
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3S
Therapeutic class — specific (HIC3) Laxatives, Local/Rectal
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name FLEET MINERAL OIL ENEMA
FDB brand name Mineral Oil Enema
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002996
  • GCN: 09049
  • GPI-14 (Medi-Span): 46400010005110
  • HICL (First Databank): 001319
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 205121
Why two NDCs? The FDA registers this code as 0132-0301-40 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00132-0301-40. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Softeners, emollients class.

Drug family (ATC) Softeners, emollients
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FLEET MINERAL OIL ENEMA Ingredient Mineral Oil
📗 Our plain-language guide HelloPharmacist
  • Mostly for occasional constipation, by mouth or as an enema. Some enemas are also used for fecal impaction or to clear residue after a barium test. One topical product is used for...
  • Take it only at bedtime and not with meals. It usually works in about 6 to 8 hours. An enema usually works within 2 to 15 minutes.
  • Space it out. Take mineral oil 2 or more hours before or after other drugs, since laxatives may affect how they work. Tell me if you take a stool softener.
  • Not longer than 1 week. If constipation continues or your bowel habits suddenly change for 2 weeks, see your doctor.
📖 Read our full Mineral Oil guide →
7
Nutrient depletion considerations

Mineral Oil may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Mineral Oil nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.017 $2.27 / 133 ml
Medicaid paysCMS SDUD · 12 mo $0.0284 $3.78 / 133 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Jan 2026 Mar 2026 Jul 2026 $0.017 $0.015
▲ Up 16% over the last 6 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00132-0301-40 You're viewing this Main listing 133 mL in 1 BOTTLE, WITH APPLICATOR 2002-05-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sunmark Mineral Oil Laxative 118 g/118mL 49348-0185-20 Strategic 1 bottle $0.014 — Availability likely save 18%
Foster and Thrive Ready to Use Mineral oil Laxative 1000 g/118mL 70677-1090-01 Strategic 1 bottle $0.014 — Availability likely save 18%
HealthMart Mineral Oil Single Laxative 118 g/118mL 62011-0270-01 Strategic 1 bottle $0.014 — FDA listed save 16%
Leader Ready to Use Mineral Oil Laxative 118 g/118mL 70000-0109-01 Cardinal 1 bottle $0.014 — FDA listed save 16%
Fleet 100 g/100mLthis 00132-0301-40 C.B. 133 ml $0.017 — Availability likely —
Pure and Gentle 100 g/100mL 53329-0013-11 Medline 1 bottle — — FDA listed —
4718 Enema, Mineral Oil 133 g/133mL 67777-0430-01 Dynarex 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2002
On the market since
May 2002
📍
2026
Currently FDA-listed
24 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

From the label’s inactive-ingredient sectionnone

This is label-wide narrative text, not a normalized exact-product ingredient list. A label can cover multiple strengths or packages.

Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerC.B. Fleet Company, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00132
First marketedMay 2002
Product typeHuman Otc Drug
Portfolio23 products on file

More NDCs from C.B. Fleet Company, Inc. labeler code 00132

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 30 words ▾

Uses for relief of fecal impaction for relief of occasional constipation for removal of residue after barium administration This product usually produces a bowel movement in 2 to 15 minutes.

⏱️ Dosage and Administration 33 words ▾

Directions Single Daily Dosage (per 24 hours) adults and children 12 years and over 1 bottle per day children 2 to under 12 years one-half bottle children under 2 years DO NOT USE

⚠️ Warnings 109 words ▾

Warnings For rectal use only . Do not use when abdominal pain, nausea, or vomiting are present unless directed by a doctor. Ask a doctor before using this product if you have a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week Stop use and ask a doctor if you have rectal bleeding no bowel movement within 15 minutes of using this product These symptoms may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 11 words ▾

Active ingredient (in each 118 mL delivered dose) Mineral oil 100%

🧪 Inactive Ingredients 3 words ▾

Inactive Ingredients none

🎯 Purpose 3 words ▾

Purpose Lubricant laxative

📄 Do Not Use 16 words ▾

Do not use when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

📄 Ask a Doctor Before Use If 30 words ▾

Ask a doctor before using this product if you have a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week

📄 Stop Use and Ask a Doctor If 28 words ▾

Stop use and ask a doctor if you have rectal bleeding no bowel movement within 15 minutes of using this product These symptoms may indicate a serious condition.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 3 words ▾

Other information sodium-free

📄 Questions or Comments 5 words ▾

Questions? 1 -866-255-6960 or www.fleetlabs.com

📄 Package Label / Principal Display Panel 37 words ▾

P RINCIPAL D ISPLAY P ANEL Fleet ® Laxative Mineral Oil enema lubricant laxative 1 bottle -

4.5 FL OZ (133 mL) Fleet® Laxative Mineral Oil enema lubricant laxative 1 bottle -

4.5 FL OZ (133 mL)

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
908
Units reimbursed last 4 qtrs
455.5K
Gross reimbursed last 4 qtrs
$12.9K
Avg / prescription
$14.26
Avg / unit
$0.0284
Latest quarter Q1 2026
263Rx
Medicaid pays / mL
$0.0284
gross reimbursed
vs
NADAC / mL
$0.0171
acquisition cost
=
Spread
+$0.0113
+66% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
35% FFS 65% MCO
Fee-for-service · 321 Rx Managed care · 587 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 5,724 units · 99.8 per 100k residents MN Wisconsin: no data reported WI Michigan: 7,714 units · 76.9 per 100k residents MI New York: no data reported NY Vermont: no data reported VT New Hampshire: 1,264 units · 90.2 per 100k residents NH Oregon: 4,256 units · 101 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 3,325 units · 48.5 per 100k residents IN Ohio: 130,087 units · 1,104 per 100k residents OH Pennsylvania: 122,281 units · 943 per 100k residents PA New Jersey: 37,373 units · 402 per 100k residents NJ Massachusetts: no data reported MA California: 112,541 units · 289 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 17,490 units · 201 per 100k residents VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 13,433 units · 181 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
48.51,104
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Ohio 1,104 /100k
2 Pennsylvania 943 /100k
3 New Jersey 402 /100k
4 California 289 /100k
5 Virginia 201 /100k
6 Arizona 181 /100k
7 Oregon 101 /100k
8 Minnesota 99.8 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 00132-0222-20 · C.B. 00132-0323-14 · C.B. →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.